Posizioni attive di Ingmar Hoerr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 11/03/2020 | - | |
| Fondatore | 11/05/2010 | - | |
| Presidente | 20/06/2018 | 11/03/2020 |
Storia della carriera di Ingmar Hoerr
Precedenti posizioni note di Ingmar Hoerr
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CUREVAC N.V. | Direttore/Membro del Consiglio | 01/01/2000 | 01/03/2020 |
| Amministratore Delegato | 01/01/2000 | 01/03/2020 | |
| Fondatore | 01/01/2000 | 01/03/2020 |
Formazione di Ingmar Hoerr
| Donau-Universität Krems | Masters Business Admin |
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 4 |
| Austria | 2 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Aziende private | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Ingmar Hoerr
- Esperienza
